ABSTRACT A system is described for solid-phase synthesis of peptides under continuous-flow conditions with liquid chromatographic equipment, conventional polystyrene supports, and welldefined chemistry. The model tetrapeptide Leu-Ala-Gly-Val was assembled in 99.3% purity in about 4 hr on microporous copoly(styrene-1% divinylbenzene). During coupling, the preformed symmetric anhydrides were conserved by being recycled. Relative yields of the peptide products were determined quantitatively in 20 min by reverse-phase high-pressure liquid chromatography. This rapid assay system was used to examine the influence on product yields of (i) the time and number of couplings per cycle, (ii) microporous versus macroporous polystyrene, and (iii) tert-butoxycarbonyl (Boc) group versus 9-fluorenylmethoxycarbonyl for amine protection. Use of microporous polystyrene and two 30-min couplings of Boc-amino acids per cycle gave the best results. This continuous-flow system provides a rapid and efficient approach to solid-phase peptide synthesis. A 17-residue peptide from chicken ovalbumin was obtained in similar purity and yield from a discontinuous synthesis and from a continuous-flow synthesis. Solid-phase peptide synthesis (1, 2) has played a major role in defining the structural features -important for the biologic activities of numerous polypeptides, including hormones, neuropeptides, and even enzymes. The discontinuous mode of operation described by Merrifield (3) in 1963 involves the addition of each reagent solution and wash solvent to the solid support in several discrete portions. and Scott et al. (5, 6) showed that solid-phase synthesis can also be performed by passing a continuous flow of each solution or solvent through a column containing the solid support. A simple, rapid, readily available, and easily automated system for solidphase peptide synthesis under continuous-flow conditions would be useful for the synthesis of large polypeptides. This paper describes a continuous-flow system based on commercially available modular equipment (7-9) for high-pressure liquid chromatography (HPLC), conventional microporous polystyrene supports, and well-established chemistry (1, 2).
Solid-phase peptide synthesis (1, 2) has played a major role in defining the structural features -important for the biologic activities of numerous polypeptides, including hormones, neuropeptides, and even enzymes. The discontinuous mode of operation described by Merrifield (3) in 1963 involves the addition of each reagent solution and wash solvent to the solid support in several discrete portions. In 1970-1972, Bayer et al. (4) and Scott et al. (5, 6) showed that solid-phase synthesis can also be performed by passing a continuous flow of each solution or solvent through a column containing the solid support. A simple, rapid, readily available, and easily automated system for solidphase peptide synthesis under continuous-flow conditions would be useful for the synthesis of large polypeptides. This paper describes a continuous-flow system based on commercially available modular equipment (7-9) for high-pressure liquid chromatography (HPLC), conventional microporous polystyrene supports, and well-established chemistry (1, 2) .
MATERIALS AND METHODS
Continuous-Flow Synthesis. The model tetrapeptide LeuAla-Gly-Val (3, 10, 11) was assembled under continuous-flow conditions with a commercial HPLC system (Waters Associates) consisting of a model 6000A pump, model U6K manual sample injector, model 440 dual-wavelength UV monitor, and a stainless steel column (0.39-cm inner diameter by 6-cm length) bearing 10-gtm inlet and outlet filters (Fig. 1) . Two manual threeway valves present on the pump were used to control the flow of liquids through the solid support in the column. Valve 1 was used to select the source of new liquid entering the pump and valve 2 was employed to direct the liquid leaving the detector. Four pump-head microfilters were replaced by large-bore washers to prevent their clogging with particulate matter, which increases the back pressure and can cause extrusion ofthe polystyrene beads through the column outlet filter (7) . The resulting column back pressure ranged from 500 to 1000 pounds per square inch gauge (psig). In addition, cavitation and degassing of CH2CI2 solutions as they were drawn into the pump heads was minimized by maintaining the acid, wash, and base reservoirs under slight nitrogen pressure (4 psig).
A typical synthetic cycle used dichloromethane (freshly distilled from anhydrous Na2CO3) as solvent, tert-butoxycarbonyl (Boc) amino acids, and phenylacetamidomethyl (PAM)-modified polystyrene. A column containing Boc-Val-OCH2-PAMpolystyrene (10) beads (200-400 mesh; 0. 08-0. 1 g) was pumped with various solutions at 4.0 ml/min.
Step 1. The Boc-amino groups were deprotected by pumping for 5 min a solution: containing 0.01 M methanesulfonic acid and 0.10 M trifluoroacetic acid from the acid reservoir through valve 1, pump, injector, column, detector, and valve 2 to waste.
Step 2. Valve 1 was turned to the wash reservoir and solvent was pumped for 4 min through the column to waste.
Step 3. The resulting protonated amino groups were neutralized by turning valve 1 to the base reservoir and pumping for 1 min a solution of0.35 M triethylamine through the column to waste.
Step 4.
Step 2 was repeated.
Step 5. A solution of Boc-amino acid symmetric anhydride was prepared in advance by reaction of the thin-layer chromatography (TLC)-pure Boc-amino acid (2.0 equiv.) and N,N'-dicyclohexylcarbodiimide (1.0 equiv.) in CH2CI2 for 10 min at 20-25TC. The resulting mixture was microfiltered twice (Millipore filter FHLP 013) to remove the precipitated dicyclohexylurea. The anhydride solution was adjusted to 0.175 M and placed in the 2-ml sample loop of the manual sample injector. As soon as this solution was injected, valve 2 was turned so that the liquid leaving the detector was recycled (Fig. 1) through the pump, injector, column, and detector for 30 min to conserve the valuable, slowly reacting anhydride solution. The 3.5-ml recycled volume consisted of 2 ml in the sample injection loop, 0.6 ml in the column, and 0.9 ml in the tubing. Thus, the concentration of symmetric anhydride in the column was 0.175 M during the first pass through the column (0.5 min) and was diluted to about 0.10 M during subsequent passes.
Step 6. Valve 2 was turned to waste and step 2 was repeated.
Steps 7-10. Steps 3-6 were repeated. The elapsed time per synthetic cycle was 83 min.
This synthetic cycle was carried out three times to couple successively Boc-Gly, Boc-Ala, and Boc-Leu to the support. Boc-Leu-Ala-Gly-Val-OCH2-PAM-polystyrene was removed from the column and treated with anisole/liquid HF, 1:9 (vol/ vol), for 1.0 hr at 0°C to obtain the free tetrapeptide and any deletion peptide by-products. The reaction mixture was washed with ether and extracted with 1% aqueous acetic acid. The extract was lyophylized and redissolved in microfiltered water (Millipore Milli-Q system) for analysis.
Peptide Analysis. Authentic samples of Leu-Ala-Gly-Val and its single-deletion and double-deletion peptides were synthesized by the solid-phase method, purified by reverse-phase HPLC, and shown to be homogeneous by amino acid analysis and by TLC in two systems ( RESULTS AND DISCUSSION Peptide Chemistry. Solid-phase peptide synthesis can be carried out in the continuous-flow mode with the same reagents and reactions normally used in the discontinuous mode. Specifically, protonated CF3COOH is used for deprotection of the Boc-amino group, triethylamine is employed for neutralization of the resulting protonated amino group, and a Boc-amino acid symmetric anhydride is used to couple the next amino acid. Although 6.5 M CF3COOH in CH2Cl2 is used for deprotection in the discontinuous mode (1, 2), 0.01 M CH3SO2OH/ 0. 10 M CF3COOH in CH2C121 was used in the continuous-flow mode to minimize abrupt changes in resin swelling and potential corrosion of the pump during extended use. This solution contains the same deprotecting species present in 6.5 M CF3COOH, which is not neutral CF3COOH but its conjugate acid, CF3C(OH)2+ (Fig. 3) (10, 12) , it was used to explore the efficiency of solid-phase synthesis in the continuous-flow mode.
Relative molar yields of Leu-Ala-Gly-Val and its deletion byproducts have been determined by low-pressure ion-exchange chromatographic separation and ninhydrin detection (13, 14) . We have developed an alternate method that uses reversephase HPLC separation and UV detection (9) . Injection By-Product Distribution. Incomplete coupling during the first synthetic cycle gives the deletion peptide Leu-Ala-Val, during the second cycle produces Leu-Gly-Val, and during the last cycle yields Ala-Gly-Val, whereas Leu-Val arises through incomplete coupling during both the first and second cycles. The yields of each of these by-products were measured quantitatively by reverse-phase HPLC (Table 3) .
The use of microporous HOCH2-PAM-polystyrene as the solid support and just one 30-min coupling per cycle ( synthesis S-7) gave only 89% of the desired tetrapeptide and substantial amounts of each of the three single-deletion peptides. With two 30-min couplings per cycle (Table 3 , synthesis S-8), the yield of Leu-Ala-Gly-Val was 98.3%.
Two syntheses were also conducted on reaction scales (0.1 and 0.45 mmol) comparable to those used in peptide research. The concentration of Boc-amino acid symmetric anhydride and the times for each synthetic operation were maintained, but the amount of resin was increased 7-fold (Table 3 , synthesis S-9) and, in addition, the amino acid loading was increased 5-fold (synthesis S-10). These syntheses used 10 and 2.2 molar equiv. ofeach symmetric anhydride, respectively. Since >99% ofboth product mixtures was the desired tetrapeptide, product purity was unaffected by a 34-fold increase in the scale ofthe synthesis. Synthesis S-10 gave 150 mg of the tetrapeptide. Thus, solidphase synthesis under continuous-flow conditions has furnished this model peptide in the same high purity obtained by addition ofeach solvent and solution in several discrete portions (10, 12, 13) .
Macroporous Support. A macroporous polystyrene support, which consisted of a rigid, highly crosslinked matrix containing large connected pores, was aminomethylated (14) and coupled with Boc-Val-oxymethylphenylacetic acid (10) . This support, which did not swell in CH2C12, gave only 87% of the desired peptide and substantial amounts of two deletion peptides with one coupling step per cycle ( cm column pumped at 6 ml/min. t L, leucine; A, alanine; G, glycine; V, valine. t Soluble Fmoc-peptides were deprotected with 1 M piperidine in dioxane/water, 1:1 (vol/vol). § Soluble Fmoc-peptides were deprotected with 2 M piperidine in DMF, and the resulting free peptides were precipitated by addition of ether.
under moderately acidic conditions [CF3C(OH)2+]. Separate neutralization with a basic solution was not needed.
4-(Hydroxymethyl)phenoxymethyl-copoly(styrene-1% divinylbenzene) was esterified by using Fmoc-Val, N,N'-dicyclohexylcarbodiimide, and 4-(dimethylamino)pyridine (17) . LeuAla-Gly-Val was assembled by successive addition of Fmocamino acid symmetric anhydrides (17, 18) . The Fmoc group was removed by treatment for 5 min with 2.0 M piperidine in dimethylformamide (DMF) (18) . In order to use this solution, a second model 6000A pump and a model 660 solvent programmer were added to the manual synthesizer. The wash step before deprotection consisted of a 5-min treatment with CH2C12, a 4-min linear gradient from CH2C12 to DMF, and a 1-min treatment with DMF. Conversely, the wash step after deprotection consisted of a 2-min treatment with DMF, a 5-min linear gradient from DMF to CH2C12, and a 5-min treatment with CH2C12. Use of these gradients avoided abrupt changes in the solvent composition and the volume of the solid support.
After removal of the resin from the synthesizer, the peptide was cleaved by treatment for 1.0 hr with 6.5 M CF3COOH in CH2C12 (17) . However, cleavage by the CH3SO2OH/ CF3COOH solution in the continuous-flow synthesizer was inefficient. Treatment of Fmoc-Val-resin (0.10 g, 44 ,mol of valine) with 0.01 M CH3SO2OH/0.10 M CF3COOH at 4.0 ml/ min for 30 min [120 equiv. of CF3C(OH)2+] released only 15% of the Fmoc-Val. The phenolic ring of the covalent link evidently competes with the a-carboxyl group of the ester for the fixed amount of CF3C(OH)2' available. Unlike a concentrated CF3COOH solution, which continuously generates CF3C(OH)2', the dilute CH3SO2OH/CF3COOH solution contains only 0.01 M CF3C(OH)2+ (Fig. 3) .
The mixture of Fmoc-peptides was deprotected with 1.0 M piperidine in dioxane/water, 1:1 (vol/vol), to give a mixture of free peptides. HPLC analysis showed that with both high and moderate loadings of valine (Table 3 , syntheses S-13 and S-14) 96% ofthe mixture was the desired tetrapeptide. The Fmoc-Gly couplings were incomplete for both loadings and the Fmoc-Leu coupling was incomplete for the higher loading. These results are nearly as good as those obtained using Boc protection and the PAM link. Part of the mixture of Fmoc-peptides obtained in synthesis S-14 was deprotected with 2 M piperidine in DMF, and the resulting free peptides were precipitated by addition of anhydrous ether (17) . The resulting peptide mixture (synthesis S-15) contained only about 40% of the deletion peptide Leu-Ala-Val present when the precipitation step was not used (synthesis S-14). This precipitation step should be omitted when attempting to measure the actual amounts of by-products produced during synthesis.
Ovalbumin Heptadecapeptide. Application of solid-phase peptide synthesis under continuous-flow conditions to a specific biologic problem is illustrated by synthesis of chicken ovalbumin-(238-254)-heptadecapeptide, which contains 10 of the 20 genetically coded amino acids. Studies with an ovalbumin fragment (19) and by sequence comparison (20) Two syntheses of the ovalbumin peptide were carried out in parallel on a 50-,umol scale (Table 4 ). The discontinuous synthesis used a 21-min deprotection with 6.5 M CF3COOH and two 120-min couplings with Boc-amino acid activated in situ (10) , whereas the continuous-flow synthesis employed a 6-min deprotection with the CH3SO2OH/CF3COOH solution and two 45-min couplings with preformed Boc-amino acid symmetric anhydride. The coupling times used in both syntheses were probably longer than necessary. With these procedures, the total elapsed time for each synthetic cycle was about 390 min for the discontinuous synthesis and 132 min for the continuousflow synthesis. Even shorter cycle times have been used on occasion (21) . Diisopropylethylamine was used for neutralization to minimize cyclization of the O-benzyl-aspartyl residue to an aspartimide residue during peptide assembly (22) .
The peptide mixtures obtained by cleavage with anisole/ HF were analyzed by reverse-phase HPLC with a linear gradient of 18-48% acetonitrile in 10 mM ammonium acetate (pH 5.2) and detection at 220 nm. The discontinuous-and continuous-flow products contained 74% and 72% of the desired 17- residue peptide, respectively. The major side reaction in each synthesis was aspartimide formation (1, 2, 22) . The discontinuous synthesis produced 16% of the aspartimide-247 analogue, whereas the continuous-flow synthesis gave 5.5% of this analogue and 15.5% ofits major hydrolysis product, the l3-aspartyl-247 analogue. These by-products were isolated by preparative HPLC and identified by digestion with carboxypeptidase Y fol- lowed by amino-acid analysis and by conversion of the aspartimide analogue into the f3-aspartyl analogue. The presence of these by-products, which are often formed during HF cleavage of O'-benzyl-aspartyl-containing peptides (22) , is independent ofthe physical mode ofpeptide assembly. Their presence would be minimized by protecting the aspartyl residue as the cyclohexyl ester and conducting the HF cleavage at -20°C (22) .
The relative molar percentage ofdeletion peptides produced is a useful measure ofthe efficiency ofthe two modes ofpeptide assembly. The discontinuous synthesis gave a mixture containing 9.8% of other by-products assumed to be single-deletion peptides, which corresponds to formation ofan average of0. 61% deletion peptides per cycle. The corresponding values for the contihuous-flow synthesis were 7.0% and 0.44%. These results are close to the 0. 3% ofdeletion peptides formed per cycle during large-scale synthesis S-10 of Leu-Ala-Gly-Val and during discontinuous syntheses of this tetrapeptide (14) and thymosin a-1 (23) . Thus, these discontinuous and continuous-flow syntheses provided the ovalbumin-(238-254) segment in comparable yield and purity.
Features of the Continuous-Flow System. The continuousflow system offers several practical features for stepwise synthesis of peptides. Because the entire system is closed, filling of the-reservoir vessels and loading ofthe activated amino acids are the only reagent handling steps. Subsequent addition of each liquid to the column requires only the turning of a valve. The efficiency of washing the solid support with a continuous flow of solvent is inherently greater than that with a discontinuous washing procedure. The times for deprotection, neutralization, and washing are short because addition and removal of the acid, base, and wash solutions occur at the same time as the solid support is-being treated with these solutions. The amounts of the Boc-amino acid symmetric anhydrides used are minimized by recycling them through the column. The scale of synthesis is conveniently varied by changing the size ofthe column and the flow rate.
Individual operations could be monitored by continuously measuring the UV absorbance ofthe liquid leaving the column. This approach has been used by Birr (24) 
